Zimmer Biomet’s Priority Markets Drove 2022 Growth

Zimmer Biomet reported 4Q22 orthopedic sales of $1.8 billion, +2.7% compared to the fourth quarter of 2021. For the full-year, the company generated $6.9 billion in orthopedic sales, representing growth of +1.6% compared to 2021.

Excluding currency translation headwinds, the company grew +8.9% for the fourth quarter and +6.6% for the year....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us